Iontophoresis in Psoriasis

NCT03979664 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped FDA did not provide approval of the use of the drug for the study

Conditions

Psoriasis
Psoriasis Vulgaris
Skin Diseases

Interventions

DEVICE: Activapatch intellidose 2.5 using active Iontophoresis
DEVICE: Activapatch intellidose 2.5 using inactive Iontophoresis
DRUG: Dexamethasone

Sponsor

Wake Forest University Health Sciences